In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
- PMID: 9366560
- PMCID: PMC508446
- DOI: 10.1172/JCI119788
In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
Abstract
The most common cystic fibrosis transmembrane conductance regulator mutation, delta F508-CFTR, is a partially functional chloride channel that is retained in the endoplasmic reticulum and degraded. We hypothesize that a known transcriptional regulator, sodium 4-phenylbutyrate (4PBA), will enable a greater fraction of delta F508-CFTR to escape degradation and appear at the cell surface. Primary cultures of nasal polyp epithelia from CF patients (delta F508 homozygous or heterozygous), or the CF bronchial epithelial cell line IB3-1 (delta F508/W1282X) were exposed to 4PBA for up to 7 d in culture. 4PBA treatment at concentrations of 0.1 and 2 mM resulted in the restoration of forskolin-activated chloride secretion. Protein kinase A-activated, linear, 10 pS chloride channels appeared at the plasma membrane of IB3-1 cells at the tested concentration of 2.5 mM. Treatment of IB3-1 cells with 0.1-1 mM 4PBA and primary nasal epithelia with 5 mM 4PBA also resulted in the appearance of higher molecular mass forms of CFTR consistent with addition and modification of oligosaccharides in the Golgi apparatus, as detected by immunoblotting of whole cell lysates with anti-CFTR antisera. Immunocytochemistry in CF epithelial cells treated with 4PBA was consistent with increasing amounts of delta F508-CFTR. These data indicate that 4PBA is a promising pharmacologic agent for inducing correction of the CF phenotype in CF patients carrying the delta F508 mutation.
Similar articles
-
Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.Pediatr Res. 2002 Nov;52(5):628-35. doi: 10.1203/00006450-200211000-00005. Pediatr Res. 2002. PMID: 12409506
-
Pharmacologic restoration of delta F508 CFTR-mediated chloride current.Kidney Int. 2000 Mar;57(3):832-7. doi: 10.1046/j.1523-1755.2000.00922.x. Kidney Int. 2000. PMID: 10720936 Review.
-
Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.Hepatology. 1999 Jun;29(6):1624-34. doi: 10.1002/hep.510290634. Hepatology. 1999. PMID: 10347100
-
A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.Am J Respir Crit Care Med. 1998 Feb;157(2):484-90. doi: 10.1164/ajrccm.157.2.9706088. Am J Respir Crit Care Med. 1998. PMID: 9476862 Clinical Trial.
-
Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.Wien Klin Wochenschr. 1997 Jun 27;109(12-13):457-64. Wien Klin Wochenschr. 1997. PMID: 9261986 Review.
Cited by
-
A Proximity Complementation Assay to Identify Small Molecules That Enhance the Traffic of ABCA4 Misfolding Variants.Int J Mol Sci. 2024 Apr 20;25(8):4521. doi: 10.3390/ijms25084521. Int J Mol Sci. 2024. PMID: 38674104 Free PMC article.
-
Endoplasmic reticular stress as an emerging therapeutic target for chronic pain: a narrative review.Br J Anaesth. 2024 Apr;132(4):707-724. doi: 10.1016/j.bja.2024.01.007. Epub 2024 Feb 19. Br J Anaesth. 2024. PMID: 38378384 Review.
-
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4. Cochrane Database Syst Rev. 2023. PMID: 37983082 Review.
-
Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel.Molecules. 2023 Apr 8;28(8):3317. doi: 10.3390/molecules28083317. Molecules. 2023. PMID: 37110551 Free PMC article.
-
4-phenylbutyric acid-Identity crisis; can it act as a translation inhibitor?Aging Cell. 2022 Dec;21(12):e13738. doi: 10.1111/acel.13738. Epub 2022 Nov 14. Aging Cell. 2022. PMID: 36373957 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical